Dupont Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-517
Closed -$53.5K 808
2022
Q4
$53.5K Sell
517
-2,649
-84% -$274K ﹤0.01% 1053
2022
Q3
$268K Buy
3,166
+1,333
+73% +$113K 0.02% 794
2022
Q2
$152K Buy
1,833
+507
+38% +$42K 0.01% 1060
2022
Q1
$102K Buy
1,326
+42
+3% +$3.23K ﹤0.01% 1253
2021
Q4
$113K Buy
+1,284
New +$113K ﹤0.01% 1271
2021
Q3
Sell
-2,190
Closed -$183K 1729
2021
Q2
$183K Hold
2,190
﹤0.01% 1320
2021
Q1
$165K Buy
2,190
+307
+16% +$23.1K ﹤0.01% 1301
2020
Q4
$165K Sell
1,883
-586
-24% -$51.3K ﹤0.01% 1165
2020
Q3
$188K Sell
2,469
-8,370
-77% -$637K ﹤0.01% 1132
2020
Q2
$1.34M Sell
10,839
-614
-5% -$75.7K 0.03% 414
2020
Q1
$968K Buy
11,453
+4,371
+62% +$369K 0.02% 463
2019
Q4
$599K Buy
7,082
+2,135
+43% +$181K 0.01% 752
2019
Q3
$333K Sell
4,947
-1,175
-19% -$79.1K 0.01% 955
2019
Q2
$524K Sell
6,122
-2,469
-29% -$211K 0.01% 763
2019
Q1
$763K Hold
8,591
0.02% 618
2018
Q4
$732K Buy
8,591
+3,542
+70% +$302K 0.02% 620
2018
Q3
$490K Buy
+5,049
New +$490K 0.01% 721
2018
Q2
Sell
-1,717
Closed -$139K 981
2018
Q1
$139K Sell
1,717
-146
-8% -$11.8K ﹤0.01% 854
2017
Q4
$166K Sell
1,863
-3,900
-68% -$348K ﹤0.01% 804
2017
Q3
$536K Buy
5,763
+3,900
+209% +$363K 0.01% 665
2017
Q2
$169K Sell
1,863
-417
-18% -$37.8K ﹤0.01% 827
2017
Q1
$200K Hold
2,280
﹤0.01% 810
2016
Q4
$189K Buy
+2,280
New +$189K ﹤0.01% 787